...
首页> 外文期刊>Annals of allergy, asthma, and immunology >Comparison of conventional and component-resolved diagnostics by two different methods (Advia-Centaur/Microarray-ISAC) in pollen allergy.
【24h】

Comparison of conventional and component-resolved diagnostics by two different methods (Advia-Centaur/Microarray-ISAC) in pollen allergy.

机译:通过两种不同的方法(Advia-Centaur / Microarray-ISAC)对花粉过敏的常规诊断和成分诊断的比较。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Component-resolved diagnostics (CRD) has recently been introduced into clinical allergology. OBJECTIVE: The aim of this study was to assess the contribution that this new diagnostic technique makes to conventional diagnosis in patients with pollen allergy, comparing CRD with conventional technologies, and to compare 2 CRD methods, Advia-Centaur and Microarray-ISAC. METHODS: Serum samples from 120 pollen-allergic patients were obtained. Immunoglobulin (Ig) E to total extracts (CAP System) and individual allergens using both CRD methods were determined. RESULTS: The 3 diagnostic methods were in agreement in 62.5% of cases. In 30%, the CRD modified the conventional diagnosis either by detecting new relevant sensitizations (mainly to Olea) or by ruling out clinically irrelevant sensitizations caused by panallergens. The main differences between the 2 CRD methods were the deficiency in the ISAC version we used (ISAC-CRD-89) to detect sensitizations to Salsola and Plantago and that Advia-Centaur did not detect sensitizations to cypress. For all allergens except for Par j 1, a significant association in the frequency of sensitization was seen with the 2 CRD techniques and good agreement when comparing the results of the 2 methods in all cases. Significant correlation was found in the concentration of specific IgE in the 2 techniques for the most prevalent allergens in our setting. The results of the different profilins analyzed using Microarray-ISAC were superimposable although somewhat lower in the case of Phl p 12. CONCLUSIONS: Component-resolved diagnostics modified the conventional diagnosis in 30% of cases. The results from the 2 CRD methods showed good agreement and correlation for most allergens.
机译:背景:成分分辨诊断(CRD)最近已被引入临床变态反应学。目的:本研究的目的是评估这种新的诊断技术对花粉过敏患者常规诊断的贡献,将CRD与常规技术进行比较,并比较两种CRD方法,即Advia-Centaur和Microarray-ISAC。方法:从120名花粉过敏患者中获得血清样本。使用两种CRD方法测定了总提取物(CAP System)的免疫球蛋白(Ig)E和单个过敏原。结果:3种诊断方法在62.5%的病例中相符。在30%的人群中,CRD通过检测新的相关致敏作用(主要是针对Olea)或排除由全变应原引起的临床上不相关的致敏作用,从而改变了常规诊断。两种CRD方法之间的主要区别是,我们使用的ISAC版本(ISAC-CRD-89)缺乏检测Salsola和Plantago的致敏性,而Advia-Centaur没有检测到对柏树的致敏性。对于除Par j 1以外的所有过敏原,在两种情况下比较两种方法的结果时,使用两种CRD技术均发现致敏频率有显着关联,并且一致性良好。在我们所研究的最普遍的过敏原的两种技术中,发现特定IgE的浓度之间存在显着相关性。使用Microarray-ISAC分析的不同蛋白的结果是可叠加的,尽管在Phl p 12的情况下要低一些。结论:在30%的病例中,通过组分解析的诊断方法可以改进常规诊断方法。两种CRD方法的结果对大多数过敏原显示出良好的一致性和相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号